Why the study?
Does mexiletine increase the defibrillation threshold in dogs?
Does mexiletine increase the defibrillation threshold in dogs?
Mexiletine does not increase the defibrillation threshold in a canine model, suggesting it may not adversely affect defibrillation energy requirements.
Answers are grounded in this paper and cite their sources.
Suggests mexiletine use without DFT concerns in canines; leaves open human applicability.
Many of the antiarrhythmic drugs produce a rise in the ventricular defibrillation threshold (DFT). Although mexiletine has also been reported as the probable cause of a significant elevation of DFT, there has been no previous study; therefore, the effect of mexiletine on DFT was investigated in the present study. The experiments were performed on ten mongrel dogs in the open-chest state using general anesthesia. Mexiletine 1, 2, 4, 6, or 8 mg/kg was administered as the loading dose, followed by the same dose/kg per hour. In these five groups, fibrillation/defibrillation (F/D) trials were performed repeatedly every 10 minutes, until 60 minutes after starting the maintenance dose. F/D trials were also performed at 30, 45, and 60 minutes after the completion of mexiletine infusion. The heart was allowed to fibrillate for a total of 30 seconds. Applying internal paddles to the heart, energies of 2, 3, 5, 7, 10, 20, and 30 J maximum were used. The minimal energy shock that caused defibrillation was defined as the DFT. The mexiletine concentration in each group changed from 0 to 6.11 micrograms/mL, DFT ranged from 2-10 J, and no statistical correlation was found between mexiletine concentration and DFT. We conclude that mexiletine does not induce an increase in DFT in dogs.
No takes yet. Share an insight, caveat, or question.
Sato et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: